Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

IRMD Stock Annual Income Statement. Download in Excel

iRadimed Corporation logo

iRadimed Corporation

Sector: Healthcare   

Industry: Medical Devices

54.65
 
USD
  
1.30
  
(2.44%)
Previous close: 53.35  Open: 53.26  Bid: 21.85  Ask: 69.75
52 week range    
40.18   
   57.95
Mkt Cap: 672 M  Avg Vol (90 Days): 40,250
Peers   
MLSS / 
NUVA / 
COO / 
Last updated: Sunday 22nd December 2024

Stock Rankings

67
MarketXLS Rank
60
Value
84
Technical
57
Quality
How are these ranks calculated?
Search for a stock

Financials

IRMD Income Statement

Annual
Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
Amortization of intangibles-38499.0-36006.0-18017.0-82399.0-89333.089963.092945.0101735.0101122.0140731.0
Basic EPS from continuing operations0.850.110.761.021.36
Basic EPS total0.230.680.670.050.590.850.110.761.021.36
Basic weighted shares outstanding9 M11 M11 M11 M11 M11 M12 M12 M13 M13 M
Cost of sales-3 M-6 M-6 M-6 M-7 M9 M8 M10 M12 M15 M
Depreciation-110557.0-187936.0-230282.0-362872.0-470395.0501218.0510652.0532275.0569551.0648133.0
DepreciationAndAmortization-110557.0-187936.0-230282.0-362872.0-470395.0501218.0510652.0532275.0569551.0648133.0
Diluted EPS total0.20.60.60.040.520.780.110.741.021.35
Diluted normalized net income/share0.780.110.741.021.35
Diluted weighted shares outstanding10 M13 M12 M12 M12 M12 M12 M13 M13 M13 M
GainOnSaleOfPPE-12473.0
GainOnSaleOfSecurity34693.089337.063045.0-6761.0-29308.010764.017272.018593.08025.0
GeneralAndAdministrativeExpense5 M8 M9 M9 M9 M10 M12 M10 M11 M15 M
Gross operating profit12 M26 M26 M18 M23 M30 M24 M32 M41 M50 M
ImpairmentOfCapitalAssets-55433.0
Income before tax3 M12 M11 M1 M6 M9 M-616878.010 M16 M22 M
Income restructuring and M&A10 M
Income taxes966975.04 M4 M896622.0-106143.0-587642.0-2 M510816.03 M5 M
Interest income-48549.0121385.032680.0111377.0193537.0388801.0132185.034806.0581852.02 M
InterestExpenseNonOperating10 M
MarketingExpense-65369.0-66722.0-136170.0-118975.0-123451.0155983.06959.095933.0
MiscOtherSpecialCharges2719.052.0-2048.0395912.0139213.018605.0553104.02 M
Net income from total operations2 M8 M7 M499764.06 M10 M1 M9 M13 M17 M
NetIncomeCommonStockholders2 M8 M7 M499764.06 M10 M1 M9 M13 M17 M
NetIncomeContinuousOperations2 M8 M7 M499764.06 M10 M1 M9 M13 M17 M
NetNonOperatingInterestIncomeExpense-48549.0121385.032680.0111377.0193537.0388801.0132185.034806.0581852.02 M
NonRecurringOperationExpense146000.0
Normalized income18 M
Operating income3 M12 M11 M1 M6 M9 M-756091.010 M16 M20 M
Operating income before depreciation (EBITDA)3 M12 M12 M3 M7 M10 M582733.011 M16 M21 M
OperatingExpense-9 M-14 M-15 M-16 M-17 M21 M24 M22 M26 M30 M
Other income net-37412.0-89389.0-60997.06761.029308.08 M8 M-18605.0-28748.0-161315.0
Other special charges9 M
OtherGandA5 M8 M9 M9 M9 M10 M12 M10 M11 M15 M
OtherImpairmentOfCapitalAssets9 M8 M
OtherOperatingExpenses409594.0409594.0467572.0534468.0675190.0
RentAndLandingFees5 M8 M9 M9 M9 M
Research & development expense1 M2 M1 M2 M2 M1 M2 M2 M2 M3 M
ResearchExpense1 M2 M1 M2 M2 M1 M2 M2 M2 M3 M
RestructringAndMnAIncome10 M
Revenue per share-38499.0-36006.0-18017.0-82399.0-89333.089963.092945.0101735.0101122.0140731.0
SalariesAndWages-724063.0-1 M-2 M-2 M-2 M8 M1 M1 M2 M
SecuritiesAmortization12 M15 M
Selling Gen & administrative expense8 M12 M14 M15 M16 M20 M22 M20 M23 M27 M
SellingAndMarketingExpense3 M5 M5 M6 M7 M9 M10 M11 M13 M12 M
SellingExpense3 M5 M5 M6 M7 M
Special income/charges55433.0-9 M-10 M
Total Income available for interest expense (EBIT)3 M12 M11 M1 M6 M9 M-756091.010 M16 M20 M
Total common shares outstanding11 M11 M11 M11 M11 M12 M12 M13 M13 M13 M
Total net income2 M8 M7 M499764.06 M10 M1 M9 M13 M17 M
Total ordinary shares13 M13 M13 M13 M13 M13 M13 M13 M13 M13 M
Total revenues16 M32 M32 M23 M30 M39 M32 M42 M53 M66 M
TotalExpenses-13 M-20 M-22 M-22 M-24 M30 M32 M32 M38 M46 M
TotalRevenue16 M32 M32 M23 M30 M39 M32 M42 M53 M66 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University